Skip to content
Startups

nference Partners with Cedars-Sinai to Build AI Clinical Research Platform

nference healthcare AI platform designed to analyse multimodal clinical data for biomedical research.

Healthcare AI company nference has entered a long-term strategic partnership with Cedars-Sinai to develop a secure platform for analysing de-identified, multimodal clinical data. Announced on November 20, 2026, the collaboration aims to help researchers examine information generated across different areas of patient care and accelerate biomedical discovery.

The planned platform will bring together clinical records, medical imaging, laboratory results, genomic information and other healthcare data. Using nference's federated software, the system is designed to harmonise these different formats while protecting patient identities and organising information across longitudinal medical histories.

nference Cedars-Sinai Partnership Focuses on Multimodal Data

A central objective of the nference Cedars-Sinai partnership is to make complex clinical information more useful for scientific research. Medical records often contain information in different formats, including physician notes, diagnostic reports, imaging files and physiological measurements. Analysing these sources together can help researchers investigate disease patterns that may not be apparent when individual data types are examined separately.

The platform is expected to incorporate de-identified clinical notes, laboratory results, medications, radiology and pathology images, genomic information, electrophysiology waveforms, vital signs and patient-consented biospecimens.

nference will use its federated software to harmonise these records and support longitudinal curation with physician adjudication. The approach is intended to organise clinical information over time while incorporating medical review into the preparation of research-ready datasets.

The company said its technology draws on more than a decade of longitudinal records from over five million patients, with frequent updates as routine care progresses. This wider data foundation is intended to help researchers examine how diseases emerge and develop over time.

Research, AI Models and Drug Discovery

Cedars-Sinai researchers are expected to use the platform for investigator-led studies, grant-funded projects, education and quality improvement. The collaboration will also support work with life sciences companies.

Another objective is to give researchers and affiliated innovators a foundation for developing and evaluating new AI models. Potential applications include drug discovery, clinical trial design and future diagnostic technologies.

These are intended research applications rather than confirmed clinical outcomes. The announcement does not establish that the platform has already produced new diagnostic tools or improved patient treatment.

Venky Soundararajan, founder and co-CEO of nference, said the collaboration would support a broader approach to understanding health and disease by connecting information across organs, clinical modalities and patient histories.

Sumeet Chugh, vice dean and chief artificial intelligence health research officer at Cedars-Sinai, said the institution expects the partnership to help clinicians and scientists learn from collective patient-care experience, validate research hypotheses and accelerate biomedical discovery.

Privacy and Longitudinal Clinical Records

Protecting patient information is a central part of the planned infrastructure. nference said its federated software is designed to support privacy-preserving data analysis while harmonising information from different clinical sources.

The platform is also intended to receive frequent data updates as patients continue routine care. This longitudinal approach could give researchers a more detailed view of disease progression than isolated clinical snapshots.

The partnership adds Cedars-Sinai to nference's network of healthcare research collaborations, which includes institutions such as Mayo Clinic, Duke Health, Vanderbilt University Medical Center, Emory Healthcare, Banner Health, Mercy Health and Rush University System for Health.

A Growing Role for AI in Biomedical Research

The collaboration reflects a shift towards using AI not only to analyse individual medical images or records but also to connect information across different stages of patient care.

For Cedars-Sinai, the platform is intended to create new research opportunities using its clinical expertise and patient-care experience. For nference, the partnership expands its work with major healthcare institutions and strengthens its position in AI infrastructure for biomedical discovery.

The platform's research value will ultimately depend on how effectively investigators use the curated data to test hypotheses, develop models and validate findings. The announcement does not disclose financial terms, a specific launch date or a timeline for researcher access.